MedTrace Logo

Visual Performance of Clareon Vivity and PureSee IOL

NCT07165197 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-09-10

No results posted yet for this study

Summary

This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson \& Johnson)

Conditions

  • Cataract

Interventions

DEVICE

Phacoemulsification with implantation of an extended depth of focus intraocular lens

Comparison of two different Extended depth of focus intraocular lenses

Sponsors & Collaborators

  • OMIQ Research

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-27
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07165197 on ClinicalTrials.gov